PEEL Therapeutics, Inc — Form D/A
PEEL Therapeutics, Inc of SALT LAKE CITY, UT, a company, filed a Form D amendment with the SEC on 2019-02-05. The offering totals $10.0M, of which $9.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-02-05
- Form: D/A
- Accession: 0001719212-19-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $10.0M
- Amount sold: $9.3M
- Remaining: $748K
- Investors: 70
- Date of first sale: 2017-10-06
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-297059
Issuer
- Name: PEEL Therapeutics, Inc
- CIK: 0001719212
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1387 S AMBASSADOR WAY, SALT LAKE CITY, UT, 84108
- Phone: (650)464-0747
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Joshua Schiffman | Director | Salt Lake City, UT |
| Avraham Schroeder | Director | Salt Lake City, UT |
| James Levison | Executive Officer | Salt Lake City, UT |
| Joshua Schiffman | Executive Officer | Salt Lake City, UT |
| Avraham Schroeder | Executive Officer | Salt Lake City, UT |
Other filings by this issuer (1)
More